Skip to Content

End of year dates: Orders must be billed by 05/12. Merck Mexico will be closed from 18/12 to 02/01.

Merck

Toxic effects of dimethylthiourea in rats.

The Journal of laboratory and clinical medicine (1994-01-01)
C J Beehler, M E Ely, K S Rutledge, M L Simchuk, O K Reiss, P F Shanley, J E Repine
ABSTRACT

Dimethylthiourea (DMTU) is a small, highly diffusible molecule that effectively scavenges toxic oxygen metabolites in vitro and reduces oxidative injury in many biologic systems. Nonetheless, for unknown reasons, DMTU has occasionally failed to decrease damage in some systems where injury is presumed to be mediated by oxygen metabolites. We hypothesized that the inconsistent pattern of protection might partially reflect a direct toxicity of DMTU. Our results supported this premise. We found that rats treated with commonly used doses of highly purified DMTU had increased lung accumulation of intravenously injected iodine 125-labeled albumin (4 hours after DMTU treatment) and decreased blood glutathione levels (24 hours after DMTU treatment) when compared with saline-injected control rats. In contrast, rats treated with dimethylurea, a analog of DMTU, did not develop increased accumulation of labeled albumin in the lungs or decreased blood glutathione levels. We conclude that DMTU has intrinsically toxic effects in rats and that DMTU toxicity may at times obscure its protective action.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
1,1-Dimethylurea, 99%
Sign Into View Organizational & Contract Pricing
SKUPack SizeAvailabilityPrice
100 μL
1 Estimated to ship on 19 February 2025
MXP 12,107.00

To order products, please contact your local dealer.